View of PREVALENCE OF NON-ALBUMINURIC CKD, ASSOCIATED FACTORS, AND TREATMENT OUTCOMES WITH DAPAGLIFLOZIN COMBINATION THERAPY IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CHRONIC KIDNEY DISEASE AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL

Return to Article Details PREVALENCE OF NON-ALBUMINURIC CKD, ASSOCIATED FACTORS, AND TREATMENT OUTCOMES WITH DAPAGLIFLOZIN COMBINATION THERAPY IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CHRONIC KIDNEY DISEASE AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL Download Download PDF